Carrie Smith Cox, Director at ARRAY BIOPHARMA INC (ARRY), bought 5,000 shares at $23.20 ($116K) on 2019-02-19, disclosed to the SEC on 2019-02-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| OGN | BUY | 2025-05-15 | $201K | — | Filing → |
| TXN | SELL | 2023-08-03 | $5.8M | — | Filing → |
| SELB | BUY | 2022-06-15 | $150K | — | Filing → |